Israeli Scientists Claim to Create Miracle Drug That Completely Cures Cancer by Emily Jones – CBNNews
GNN Note – I’m guessing this drug will not be allowed to come to market. If it does, it will replace a multi-billion dollar industry that is a measurable percentage of most western developed nations economies. Let that sink in for just a minute. Is it in the best interest of these nations to begin shutting down hospitals, research facilities, doctors offices, manufacturing facilities and the list goes on and on of the impact the cancer industry has on an economy. Not sure the satanic globalist will allow this to happen.
JERUSALEM,Israel – A team of Israeli scientists believes it may have found the cure of all cures to finally end cancer.
“We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, chairman of the board of Accelerated Evolution Biotechnologies Ltd. (AEBi).
“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” Aridor told The Jerusalem Post. “Our solution will be both generic and personal.”
This miracle drug is called MuTaTo, or multi-target toxin. MuTaTo acts as a “cancer antibiotic” and uses a combination of cancer-targeting peptides (amino acid chains) and a toxin that specifically kills cancer cells.
The Israeli scientists studied why previous cancer drugs failed.
One reason why cancer drugs fail is because they only attack one specific target in or on one cancer cells at a time. Mutations in the cancer cells make the anti-cancer drugs ineffective.
However, MuTaTo uses several cancer-targeting peptides on a single cancer cell at once, along with a cancer-destroying toxin.
AEBi CEO Dr. Ilan Morad said by using this anti-cancer cocktail, “we made sure that the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer.”
“The probability of having multiple mutations that would modify all targeted receptors simultaneously decreases dramatically with the number of targets used,” Morad continued. “Instead of attacking receptors one at a time, we attack receptors three at a time – not even cancer can mutate three receptors at the same time.”